San Diego's Covid-19 Vaccine: What's The Latest?

did san diego find a vaccine for coronavirus

As the world continues to battle the novel coronavirus, scientists in San Diego are working tirelessly to develop a vaccine. Inovio Pharmaceuticals, a biotech company based in San Diego, is at the forefront of this effort, with its COVID-19 vaccine already in clinical trials. The company was the second in the world to test a vaccine in humans, and its unique approach uses DNA to teach the immune system to recognize the virus. While the development of a successful vaccine is challenging, the global scientific community is making significant progress, with over 135 vaccines in various stages of development. San Diego County residents can now access the 'My Turn' portal to check their eligibility for vaccination and schedule appointments, as the state streamlines the process and prioritizes specific groups based on exposure and health risks.

Characteristics Values
Location of vaccine development San Diego
Company developing the vaccine Inovio Pharmaceuticals
Type of vaccine DNA vaccine
Vaccine development stage Clinical trials
Vaccine availability Not yet available to the public
Vaccine eligibility check My Turn portal

cyvaccine

Inovio Pharmaceuticals in San Diego is working on a vaccine

Inovio Pharmaceuticals, a biotech company based in Pennsylvania, has been working on a vaccine against COVID-19 in its San Diego lab. The company was the second in the world to test a COVID-19 vaccine in humans, going from the concept stage to an experimental vaccine in just 83 days. Inovio's vaccine uses DNA to teach the immune system to recognize a piece of the novel coronavirus.

Inovio received $6.9 million in funding to launch a clinical trial in South Korea, marking the second trial for its proposed DNA-based vaccine. The company's San Diego lab supported the trial by providing analytical assays and supplying drug delivery devices. The early-stage trial involved 40 healthy adult volunteers in the U.S., receiving doses of the vaccine at the University of Pennsylvania School of Medicine and the Center for Pharmaceutical Research in Kansas City, Missouri.

Inovio's vaccine candidate is one of the most promising out of the 135 vaccines in development. The company's scientists are working at a rapid pace to create a vaccine that will stop the spread of SARS-CoV-2, the novel coronavirus that has caused a global pandemic. While developing a successful vaccine is challenging, particularly for a complex and unpredictable virus like SARS-CoV-2, Inovio's efforts are crucial in the global fight against the disease.

Following the initial safety trial, Inovio reported on the vaccine's performance and planned to move on to a larger trial if results were promising. Kate Broderick, Inovio's senior vice president of research and development, stated that the larger trial could start as early as July and conclude by the end of the year. The company's swift progress and innovative approach offer hope in the race to find an effective vaccine against COVID-19.

cyvaccine

San Diego County residents can use the My Turn portal to check eligibility

As of 2021, San Diego County residents can use the My Turn portal to check their eligibility for the COVID-19 vaccine. The My Turn portal is a California vaccine scheduling and information site that supports a range of vaccine types and options for finding a clinic. The website asks users to select a language, then click to check their eligibility. The next page asks users to confirm their eligibility through questions, including their county of residence, whether they are healthcare workers, and their age range. The portal then informs users if they are eligible for the vaccine. Eligible users are then asked to enter an address or zip code to find appointment locations and times. For those who are not eligible, the website will give the user the option to register for updates.

Inovio Pharmaceuticals, a biotech company based in San Diego, is one of the leaders in the development of a COVID-19 vaccine. The company was the second in the world to test a COVID-19 vaccine in humans, and its scientists went from the concept stage to an experimental vaccine in 83 days. The vaccine uses DNA to teach the immune system to recognize a piece of the novel coronavirus.

cyvaccine

The My Turn portal also allows eligible users to schedule a vaccination appointment

As of June 2020, scientists in San Diego were still working hard to find a vaccine for COVID-19. One of the most promising vaccines in development was by Inovio Pharmaceuticals, a biotech company based in San Diego. Inovio was the second company in the world to test a COVID-19 vaccine in humans, and its scientists were working at breakneck speed to create a vaccine.

In January 2021, the My Turn portal was launched in San Diego County to allow eligible users to schedule a vaccination appointment. The website also allows users to check their eligibility for the vaccine. My Turn is one of multiple ways to get information about the vaccine. The portal was piloted in California's two most heavily populated counties, LA and San Diego, to smooth out any issues before a statewide launch. The website asks users to select a language, then click to check their eligibility. On the next page, users are asked to confirm their eligibility through questions, including what county they live in, their age range, and whether they are healthcare workers.

The My Turn portal also supports a range of vaccine types and options for finding a clinic that meets all your needs. Users can make an appointment to get one or more vaccinations during a single visit. They can also use the Vaccine Locator to find clinics and providers that accept walk-in patients, offer the vaccines they need, and provide vaccination services based on their insurance status and ability to pay. Users can also access their digital vaccine record and get a link to a QR code and digital copy of their vaccination records.

cyvaccine

The My Turn portal is currently being piloted in LA and San Diego counties

While San Diego is home to Inovio Pharmaceuticals, which was the second company in the world to test a COVID-19 vaccine in people, the vaccine race is still ongoing. Inovio's vaccine uses DNA to teach the immune system to recognize a piece of the novel coronavirus.

In the meantime, the My Turn portal is currently being piloted in LA and San Diego counties. The My Turn portal is a website launched by the state of California to help residents determine their eligibility to receive the coronavirus vaccine. The website also allows eligible users to schedule a vaccination appointment. For those who are not yet eligible, the online tool will send an email or text notification when they become eligible.

The My Turn portal supports a range of vaccine types and options for finding a clinic. It also provides information on California's vaccination requirements for school and childcare. Users can book an appointment with their child's healthcare provider or on the My Turn portal to ensure their child is up to date on their routine vaccinations. The portal also offers a Vaccine Locator to help users find clinics and providers that accept walk-in patients, offer the vaccines they need, and provide vaccination services based on their insurance status and ability to pay.

The My Turn portal is being tested in California's two most heavily populated counties to address any issues before its statewide launch, which was initially expected to occur as early as February 2021. Gov. Gavin Newsom described the system as "the most comprehensive end-to-end system of its type in the United States."

cyvaccine

Scientists are struggling to find a vaccine that can vanquish coronavirus

Scientists are working tirelessly to find a vaccine that can vanquish the coronavirus. From San Diego to Beijing to London and Moscow, researchers are working at breakneck speed to create a vaccine that will stop the spread of a virus that has killed millions of people worldwide. There are currently at least 135 vaccines in development, a number that has doubled since March 2020.

One of the most promising vaccines comes from Inovio Pharmaceuticals in San Diego, which has been working on a COVID-19 vaccine for 20 years. Inovio was the second company in the world to test a COVID-19 vaccine in humans, and its vaccine is already in clinical trials. The company's vaccine uses DNA to teach the immune system to recognize a piece of the novel coronavirus. While Inovio's vaccine shows promise, the company's senior vice president of research and development, Kate Broderick, acknowledges that developing a successful vaccine is a complex and challenging process.

The coronavirus, formally known as SARS-CoV-2, is a fickle and baffling new virus. It causes severe symptoms in some people but not in others, making it difficult to predict and prevent its impact. Dr Davey Smith, chief of infectious diseases at UC San Diego, explains how the global effort to develop a vaccine is unfolding but notes that there is still a long way to go. The first companies to develop and manufacture safe and effective vaccines stand to gain significant financial rewards.

In the meantime, therapeutic drugs are being developed to make the disease less fatal, and one existing antiviral drug, remdesivir, shows promise in speeding up recovery times. As the world waits for a vaccine, other measures such as social distancing and mask-wearing remain crucial in controlling the spread of the virus.

Frequently asked questions

San Diego-based Inovio Pharmaceuticals is one of the leaders in the hunt for a coronavirus vaccine. The company was the second in the world to test a COVID-19 vaccine in people. Its vaccine uses DNA to teach the immune system to recognize a piece of the virus.

San Diego County residents can find out if they are eligible for the coronavirus vaccine through the My Turn portal. The website also allows eligible users to schedule a vaccination appointment.

California is currently prioritizing the vaccine for healthcare workers, residents and staff at long-term care facilities, and those aged 65 and older. After the initial cohorts, eligibility will be based on age.

Inovio's vaccine development is still ongoing. The company completed a Phase 1 safety trial involving 40 patients and will move on to a larger trial involving thousands of people if the results are promising.

Scientists in San Diego are working on various therapeutic drugs to make the disease less fatal, with one existing antiviral drug, remdesivir, showing promise for speeding up recovery times.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment